India 3D Printing Medical Devices Market Analysis

India 3D Printing
Medical Devices
Market Analysis
A sample report on
Includes Market Size, Market Segmented by
Types and Key Competitors (Data forecasts
from 2022 – 2030F)
www.insights10.com

This report presents a strategic analysis of the India 3D Printing
Medical Devices Market and a forecast for its development in the
medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, main players, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the India 3D Printing Medical Devices
Market, and offers unmatched value, accuracy, and expert insights

3
A Sample Report on India 3D Printing Medical Devices Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. 3D Printing Medical Devices Overview 08-21
1.1. Overview
1.2. India Overview
1.3. Economic Overview: India
1.4. 3D Printing Medical Devices Market in India
1.5. Medical Devices Market in India
1.6. Healthcare Scenario in India
1.7. Health Insurance Coverage: India
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 22-28
2.1. Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Component
2.2.2. By Application
2.2.3. By Technology
2.2.4. By End-user
3. Market Dynamics 29-33
3.1. Market Growth Drivers
3.1.1. India 3D Printing Medical Devices Market Driver 1
3.1.2. India 3D Printing Medical Devices Market Driver 2
3.2. Market Restraints
3.2.1. India 3D Printing Medical Devices Market Restraint 1

6
Table of Content
CONTENT PG. NO.
4. Competitive Landscape 34-44
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Formlabs
4.2.2. Osteo3d
4.2.3. Ayushman3D
4.2.4. Anatomiz3D Medtech
4.2.5. Anatomage
4.2.6. 3Dexter
4.2.7. Sahajanand Medical Technologies

7
Table of Content
CONTENT PG. NO.
4.2.8. Stratasys
4.2.9. 3D Systems
4.2.10. Materialise
5. Reimbursement Scenario 45-48
5.1. Reimbursement Regulation
5.2. Regulatory Process
6. Methodology & Scope 49-54

India 3D Printing Medical Devices Market Analysis
1. 3D Printing Medical Devices Overview

9
1.1 Statistics at a Glance: The Burden of 3D Printing Medical Devices in the
World
Prevalence of 3D Printing Medical
Devices ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2 Mn
different kinds of
medical devices are
available in the
global market
70%
is the revenue share of the
largest medical device
equipment manufacturers
located in the US
7000
of the medical devices fall into
generic devices group
$562 Bn
is the revenue forecast for
medical devices industry
by 2024
40%
US is the largest
medical device
market with 40% of
global MedTech
market
1000+
healthcare organizations
worldwide are using 3D
printing for a variety of
applications, including
medical device manufacturing

10
1.1 Statistics at a Glance: The Burden of 3D Printing Medical Devices in the
World (continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$XX Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$XX Bn
India Market
~$XXMn Market
Illustrative

11
1.2 India Overview
1.42 Bn
is the population of
India, in 2022
28.7
is the median age
in India, in 2022
3.26 Tn
is the Gross
Domestic Product
(GDP) in India in
2022
$54.32
per capita was the
amount of national
health expenditures in
2022
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

12
1.3 Economic Overview: India
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of India, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of India, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

13
1.4 Statistics at a Glance: The Burden of 3D Printing Medical Devices in India
Prevalence of 3D Printing Medical Devices
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in India
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
2000+
companies distributing
medical devices in India
3500
there are a total of 105 MRI
units in India
82%
of the medical device
expenditures in India are made
by the private sector
$222 Mn
is the projected sales
figure in the 3D Printing
Medical Devices market
in India by 2025
0.4
is the density of radiotherapy
devices per 1,000,000
population in India
18%
of the medical device
expenditures in India are
made by the public sector

14
1.5 Medical Devices in India
620 639 658 677 698 719 740 763 785
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India Medical Devices Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Medical Devices market in India, which includes the market size, current trends
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

15
1.6 Healthcare Scenario in India
3D Printing Medical Devices Drug Development Process: The process of developing a 3D Printing Medical Devices drug is complex and
involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the 3D Printing Medical
Devices drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating 3D Printing Medical Devices
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative

16
1.6 Healthcare Scenario: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative

17
1.7 Health Insurance Coverage: India
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Private (18.9%), Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Public 58,541 60,226 0.5
Private 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

18
1.8 Budget of India Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Public $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Private $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Public 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Private 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Public spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Private spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

19
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

20
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Formlabs partnership
with Stryker
Partnership
Not
Disclosed
February,
2023
▪ Formlabs and Stryker announced a partnership to develop 3D-
printed implants for orthopedic surgeries
▪ Company's technology uses a patient's CT scan data to create a
3D model of the patient's anatomy and is then used to create a
custom-fit implant that is less likely to cause complications
▪ Goal of the partnership is to develop 3D-printed implants that are
more personalized and precise than traditional implants
Anatomage
acquisition of 3D
Systems’ medical
business
Acquisition $900 Mn
February,
2023
▪ Anatomage has acquired 3D Systems' medical education
business for $900 Mn
▪ Anatomage is a medical technology company that develops and
sells 3D anatomy visualization systems for medical education and
research
▪ Acquisition will allow Anatomage to expand its product portfolio
and reach a wider audience
Latest Deals In India

21
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In India

2. Market Size and Forecasting

23
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India 3D Printing Medical Devices Market Forecast, 2022-2030 (in
$Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
India Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
India Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative
Illustrative

24
2.2 Snapshot of 3D Printing Device Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the India 3D Printing Medical Devices Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Type of Component
Equipment
Materials
Software & Services
Type of Application
Orthopedics
Dental
Reconstructive
Surgery
Cardiology
Others
Type of Technology
Stereolithography
(SLA)
Selective Laser
Sintering (SLS)
Fused Deposition
Modeling (FDM)
Others
End-User
Medical and
Surgical Centers
Pharmaceuticals
and Biotechnology
Companies
Academic
Institutions

25
India 3D Printing Medical Devices Market Share, By Component
(2022)
Software &
Services
Materials
Equipment
▪ Software & Services market in India is
a significant component of the overall
3D Printing Medical Devices treatment
market
▪ It has the maximum market share in
India 3D Printing Medical Devices
market with approximately xx%
final report
2.2.1 Market Segmentation: By Component
Illustrative

26
India 3D Printing Medical Devices Market Share, By Application
(2022)
Orthopedics
Dental
Reconstructive
Surgery
Cardiology
Others
2.2.2 Market Segmentation: By Application
▪ Orthopedics 3D Printing Medical
Devices market in India is a significant
component of the overall 3D Printing
Medical Devices market
▪ It has the maximum market share in
India 3D Printing Medical Devices
market with approximately xx%
final report
Illustrative

27
India 3D Printing Medical Devices Market Share, By Technology
(2022)
Stereolithograph
y (SLA)
Selective Laser
Sintering (SLS)
Fused
Deposition
Modeling (FDM)
2.2.3 Market Segmentation: By Technology
▪ Stereolithography (SLA) have the
maximum market share in India 3D
Printing Medical Devices market with
approximately xx%
final report
Illustrative

28
India 3D Printing Medical Devices Market Share, By End User
(2022)
Medical and
Surgical Centers
Pharmaceuticals
and
Biotechnology
Companies
Academic
Institutions
2.2.3 Market Segmentation: By End User
▪ Medical and Surgical Centers have the
maximum market share in India 3D
Printing Medical Devices market with
approximately xx%
final report
Illustrative

3. Market Dynamics

30
3.1 Market growth drivers
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 Increasing investment in research and development (R&D) for 3D printing medical devices in India is expected
to reach $1 Bn by 2025
Increase in R&D investment of 3D
Printing Medical Devices in India
Illustrative

31
3.1 Market growth drivers (continued)
Growing Prevalence of Chronic Diseases
3.1.2 Rising prevalence of chronic diseases such as cardiovascular diseases (200 Mn), chronic respiratory diseases
(100 Mn), diabetes (77 Mn), and cancer (1.2 Mn) in India
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Chronic Disease Prevalence
Cardiovascular Diseases 200 Mn
Chronic Respiratory
Disease
100 Mn
Diabetes 77 Mn
Cancer 1.2 Mn
Illustrative

32
3.2 Market restraints
3.2.1 High cost of 3D printing
technology like prosthetics ($1k
to $10k) is one of the major
restraints for the India 3D
printing medical devices market
▪ In order to obtain access to all of
the information that you are
seeking, you will need to
purchase the final report
▪ Final report will be
comprehensive and detailed, and
it will include data, analysis,
trends, and other relevant
3.2.2 Government has strict
regulations for the approval of
medical devices, which makes it
difficult for companies to bring new
3D printed medical devices to market
3.2.3 Limited awareness of 3D printing
technology among healthcare
professionals and patients is another
major restraint for the India 3D
printing medical devices market
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

34
4.1 Major Market Share
XX
Other
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Revenue of Major players in India 3D Printing Medical
Devices Market ($ Mn)
Illustrative

35
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Formlabs
3 Ayushman3D
5 Anatomage
7
Sahajanand Medical
Tchnologies
9 3D Systems
2 Osteo3d
4 Anatomiz3D Medtech
6 3Dexter
8 Stratasys
Materialise
10
Key Note:
Illustrative

36
4.2.1 Formlabs
Founded in: 2011
HQ: Somerville, Massachusetts
Type: Private
Revenue: -
Website: www.formlabs.com
▪ Formlabs is a 3D printing company that develops and
manufactures 3D printers and 3D printing materials
▪ Formlabs has raised over $200 Mn in funding from investors such
as Accel Partners, DFJ Growth, and New Enterprise Associates
▪ Formlabs' 3D printing materials are used to create a variety of
objects, including dental crowns and implants, hearing aids, and
prosthetic limbs
Industries catered by Formlabs
➢ Medical
➢ Dental
➢ Manufacturing
➢ Education
➢ Engineering
3D Printing Materials for
Healthcare
3D Printers (SLA)
Durable Resin Form 3+
BioMed White, Black, Clear,
Amber Resin
Form 3L
Tough 1500 Resin Form 3B+
PU Rigid Resins Form 3BL
Formlabs Recent Activity / Press Coverage
Announced a new flame retardant resin which is designed for use in
applications where fire safety is a concern
Formlabs named one of the best places to work in Massachusetts
Formlabs Form 3+ printer named best 3D printer for beginners, this award
is from PCMag, and it recognizes Formlabs' commitment to making 3D
printing accessible to everyone
Illustrative

37
4.2.1 Formlabs (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
One of the largest pharmaceutical
distributors in the United States, McKesson
has been a long-standing distribution
partner for Formlabs
Cardinal Health is a Fortune 500 healthcare
services company that provides
pharmaceutical distribution services to
Formlabs
It is one of the largest drugstore chains in
the United States and Europe, and its
extensive network of retail locations and
distribution centers make it an important
distribution partner for Formlabs
A leading healthcare services provider in
Asia, Zuellig Pharma is a distribution
partner for Formlabs in several Asian
countries
One of the largest pharmaceutical
wholesalers in Europe, PHOENIX Group
distributes Formlabs's products in several
European countries
Formlabs has been working with SAP, a
leading software company, to develop digital
solutions for its healthcare products
A leading Swiss biotechnology company,
Lonza provides Formlabs with contract
manufacturing services for the production of
its biologics and pharmaceuticals
Formlabs has a strategic partnership with
Microsoft to leverage its cloud computing
and AI technologies in the development of
new healthcare products
Thermo Fisher Scientific is a leading
provider of analytical instruments, reagents,
and laboratory services
GE Healthcare provides Formlabs with
advanced medical imaging and diagnostics
technologies, including CT scanners and
MRI machines
Illustrative

38
Company Name Type
Amount /
Duration
Year Key Pointers
Hawk Ridge System
Partnership
Not
Disclosed
March,
2023
▪ Formlabs announced a partnership with Hawk Ridge Systems, a
company that provides 3D printing services to businesses
▪ Partnership will allow Formlabs customers to purchase Formlabs
printers and materials through Hawk Ridge Systems
▪ Partnership between Formlabs and Hawk Ridge Systems is a
strategic one that will allow Formlabs to focus on its core
business of developing and manufacturing 3D printers
Stratasys
Partnership
Not
Disclosed
January,
2022
▪ Partnership was announced in January 2022 and aims to provide
dental professionals with a complete end-to-end solution for
digital dentistry
▪ Partnership includes the integration of Formlabs' Form 3B printer
and Stratasys' J750 Digital Anatomy printer
▪ Form 3B printer is a desktop stereolithography (SLA) printer that
is known for its high quality and ease of use and the J750 Digital
Anatomy printer is a high-end SLA printer that is used to create
detailed models of the human anatomy
Latest Deals - Mergers and Acquisitions

39
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

40
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for 3D
Printing Medical
Devices
Recent Activity / Press Coverage

41
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

42
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions

43
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

45
5.1 Reimbursement Regulation
▪ Reimbursement for 3D printing medical devices in India is still in its early
stages. There is no clear consensus on how 3D printed medical devices
should be reimbursed, and there is a lack of data on the clinical and cost-
effectiveness of these devices
▪ Some insurers in India have begun to reimburse for 3D printed medical
devices, but the coverage is often limited to specific indications. For example,
some insurers will reimburse for 3D printed implants for craniomaxillofacial
surgery, but they will not reimburse for 3D printed implants for orthopedic
surgery
▪ Lack of reimbursement for 3D printed medical devices is a major barrier to the
adoption of this technology in India. However, as the clinical and cost-
effectiveness of 3D printed medical devices becomes more established, it is
likely that insurers will begin to reimburse for these devices more widely
Public and Private together provide
health insurance coverage for more than
4 in 10 population
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

46
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Public and Private
 Public is a federal program that provides healthcare coverage to individuals who are
65 years of age or older, as well as certain younger people with disabilities
 Private is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

47
5.2 Regulatory Process for 3D Printing Medical Devices in India
Regulatory process for 3D printing medical devices in India is still evolving.
The Central Drugs Standard Control Organization (CDSCO), the regulatory
body for medical devices in India, has issued a draft guidance document on
the regulation of 3D printed medical devices. The draft guidance document
covers the following topics:
▪ Classification of 3D printed medical devices
▪ Design and manufacturing requirements
▪ Quality assurance requirements
▪ Post-market surveillance requirements
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Medical Devices and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Medical Devices
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

India 3D Printing Medical Devices Market Analysis

Recommended

Recommended

More Related Content

Similar to India 3D Printing Medical Devices Market Analysis

Similar to India 3D Printing Medical Devices Market Analysis (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

India 3D Printing Medical Devices Market Analysis